Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


QUOTED. Jan. 23, 2018. Scott Whitaker.

Executive Summary

Check out what AdvaMed CEO Scott Whitaker had to say about Congress’ move to suspend the device tax after many fits and starts in 2017.

"Congress' action to once again suspend the medical device tax – just days before companies were set to start cutting checks to the IRS – means funds will not be diverted from investing in new jobs, new capital improvements, and new treatments and cures. We appreciate Congress' action." –Scott Whitaker, president and CEO, AdvaMed

> Find out more: US Senate Votes To End Shutdown, Clinches Two-Year Device-Tax Repeal

Click here for a free trial of Medtech Insight


Related Content

US Congress Ends Shutdown, Clinches Two-Year Device-Tax Repeal





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts